Women's health is not being overlooked because we lack evidence. It is being overlooked because too many people with the power to act remain silent.

For decades, women have been more likely to have their pain dismissed, their symptoms misdiagnosed, and their conditions under-researched. Diseases affecting millions of women continue to receive disproportionately low levels of funding and attention. These are not isolated failures. They are systemic shortcomings.

Most troubling is that the people best positioned to change this reality often remain on the sidelines.

Men continue to hold many of the most influential leadership positions in healthcare, business, finance, research, and government. They help determine what gets funded, what gets prioritized, and what makes it onto the agenda. Yet when it comes to women's health, too many choose silence.

That silence is often justified as respect. Some men believe that because they don't personally experience these issues, they shouldn't engage in the conversation. But leadership is not about personal experience. It is about recognizing problems that matter and working to solve them.

Women's health is not a niche issue. It affects workforce participation, economic productivity, family stability, and community well-being. When women struggle to access timely diagnoses, effective treatments, or workplace support, the consequences ripple throughout society.

Too often, women's health is treated as a special interest rather than a societal priority. Labeling something a "women's issue" has become an easy way to push it to the margins.

That must change.

Men do not need to become experts in every aspect of women's health. But they do need to engage. They need to ask why research funding fails to match disease burden, why workplace benefits often ignore predictable health needs, and why longstanding disparities continue to be tolerated.

Most importantly, they need to speak up.

Private support is valuable, but visible leadership changes systems. Meaningful progress happens when those with influence decide an issue can no longer be ignored.

The cost of inaction is measured in delayed diagnoses, lost opportunities, diminished quality of life, and preventable suffering. Action brings healthier families, stronger communities, and better outcomes for generations to come.

The question is no longer whether men should be part of the conversation about women's health.

The question is why so many leaders with the power to accelerate change have not yet decided they must.

Silence is no longer caution.

It is complicity.

— Jeffrey Lewis is the President and CEO of Legacy Health Endowment and the EMC Health Foundation. The words expressed are his own.